×
About 5,330 results

ALLMedicine™ Hyperbilirubinemia Center

Research & Reviews  2,605 results

Is There a "Direct" Answer: Should We Perform Exchange Transfusion for Neonatal Predomi...
https://doi.org/10.1177/00099228211006686
Clinical Pediatrics; Hochwald O, Borenstein-Levin L et. al.

Apr 15th, 2021 - Is There a "Direct" Answer: Should We Perform Exchange Transfusion for Neonatal Predominantly Conjugated Hyperbilirubinemia?|2021|Hochwald O,Borenstein-Levin L,Dinur G,Kugelman A,|

Validation of published rebound hyperbilirubinemia risk prediction scores during birth ...
https://doi.org/10.1038/s41390-021-01478-7 10.1016/S2352-4642(18)30139-1 10.1056/NEJMct0708376 10.1542/peds.114.2.506 10.1542/peds.2008-2980 10.1002/ebch.1898 10.1007/s13312-010-0133-z 10.1542/hpeds.2014-0074 10.1001/archpedi.156.7.669 10.1136/adc.2005.081224 10.1111/j.1651-2227.2008.01015.x
Pediatric Research; So V, Coo H et. al.

Apr 7th, 2021 - Hyperbilirubinemia commonly affects newborns and may lead to neurotoxicity if untreated. Neonates can experience rebound hyperbilirubinemia (RHB), defined as elevated bilirubin levels requiring re-initiation of treatment. Although studies have for...

Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders...
https://doi.org/10.1038/s41390-021-01446-1 10.1038/pr.2015.134 10.1111/j.1651-2227.2011.02176.x 10.1111/j.1600-0447.1999.tb10899.x 10.1111/j.1365-3016.2008.00973.x 10.1111/jcpp.12303 10.4088/JCP.v61n0410b 10.4088/JCP.v61n1110 10.1038/s41390-018-0216-4 10.1097/00005072-196707000-00003 10.1016/S0022-3476(69)80351-3 10.1016/j.pnpbp.2009.02.013 10.1016/j.pnpbp.2013.12.017 10.1038/pr.2014.199 10.1016/0014-2999(82)90599-4 10.1016/S0021-9258(19)30079-1 10.1073/pnas.1323287111 10.1016/j.physbeh.2019.02.006 10.1016/j.brainresprot.2004.04.002 10.1093/nar/gku1026 10.1016/j.heliyon.2019.e02037 10.1016/0006-8993(85)90857-1 10.1016/j.neubiorev.2005.06.007 10.1016/j.tins.2007.03.006 10.1038/sj.jp.7211157 10.1007/s12035-011-8214-0 10.1016/S0028-3908(97)00051-8 10.1016/S0006-8993(99)01224-X 10.1211/jpp/61.09.0016 10.1016/S0014-2999(98)00591-3 10.1152/physrev.00015.2019 10.3389/fncir.2020.590299 10.3389/fnins.2017.00295 10.1016/0014-4886(82)90115-7 10.1001/archneur.1979.00500390067007 10.1186/1742-2094-10-145 10.1186/s12974-016-0688-2 10.1002/brb3.1028 10.1177/1178646919873925 10.1016/S0140-6736(05)66915-2 10.1038/sj.mp.4002100 10.1186/s13229-018-0243-3 10.1038/sj.npp.1300476 10.1055/s-2007-1014472
Pediatric Research; Miura S, Tsuchie K et. al.

Apr 1st, 2021 - Severe neonatal hyperbilirubinemia has been known to cause the clinical syndrome of kernicterus and a milder one the syndrome of bilirubin-induced neurologic dysfunction (BIND). BIND clinically manifests itself after the neonatal period as develop...

The Enigma of Preterm Late Hyperbilirubinemia Kernicterus in Japan.
https://doi.org/10.1159/000514758
Neonatology Watchko JF

Mar 28th, 2021 - The Enigma of Preterm Late Hyperbilirubinemia Kernicterus in Japan.|2021|Watchko JF,|

Neonatal hereditary spherocytosis caused by a de novo frameshift mutation of the SPTB g...
https://doi.org/10.1097/MD.0000000000024804
Medicine Zhang Y, Shao S et. al.

Mar 25th, 2021 - The etiology of non-immune hydrops fetalis is complex, and its prognosis is poor. One of its main causes is anemia. There are few reports on hydrops fetalis due to anemia caused by hereditary spherocytosis (HS), especially regarding its occurrence...

see more →

Guidelines  7 results

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Ata...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.

Sep 29th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or ...
https://doi.org/10.1542/peds.2011-1494
Pediatrics Bhutani VK, et. al.

Sep 28th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy...
https://www.ncbi.nlm.nih.gov/pubmed/20704172
American Family Physician;

Aug 13th, 2010 - Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: recommendation statement.|2010| ,|blood,diagnosis,prevention & control,

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1751-486X.2010.01516.x
Nursing for Women's Health;

Feb 8th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1552-6909.2009.01098.x
Journal of Obstetric, Gynecologic, and Neonatal Nursing :...

Dec 30th, 2009 - Universal screening for hyperbilirubinemia.|2009| ,|diagnosis,etiology,prevention & control,methods,standards,methods,nursing,standards,

see more →

Drugs  4 results see all →

Clinicaltrials.gov  2,653 results

Is There a "Direct" Answer: Should We Perform Exchange Transfusion for Neonatal Predomi...
https://doi.org/10.1177/00099228211006686
Clinical Pediatrics; Hochwald O, Borenstein-Levin L et. al.

Apr 15th, 2021 - Is There a "Direct" Answer: Should We Perform Exchange Transfusion for Neonatal Predominantly Conjugated Hyperbilirubinemia?|2021|Hochwald O,Borenstein-Levin L,Dinur G,Kugelman A,|

Validation of published rebound hyperbilirubinemia risk prediction scores during birth ...
https://doi.org/10.1038/s41390-021-01478-7 10.1016/S2352-4642(18)30139-1 10.1056/NEJMct0708376 10.1542/peds.114.2.506 10.1542/peds.2008-2980 10.1002/ebch.1898 10.1007/s13312-010-0133-z 10.1542/hpeds.2014-0074 10.1001/archpedi.156.7.669 10.1136/adc.2005.081224 10.1111/j.1651-2227.2008.01015.x
Pediatric Research; So V, Coo H et. al.

Apr 7th, 2021 - Hyperbilirubinemia commonly affects newborns and may lead to neurotoxicity if untreated. Neonates can experience rebound hyperbilirubinemia (RHB), defined as elevated bilirubin levels requiring re-initiation of treatment. Although studies have for...

Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders...
https://doi.org/10.1038/s41390-021-01446-1 10.1038/pr.2015.134 10.1111/j.1651-2227.2011.02176.x 10.1111/j.1600-0447.1999.tb10899.x 10.1111/j.1365-3016.2008.00973.x 10.1111/jcpp.12303 10.4088/JCP.v61n0410b 10.4088/JCP.v61n1110 10.1038/s41390-018-0216-4 10.1097/00005072-196707000-00003 10.1016/S0022-3476(69)80351-3 10.1016/j.pnpbp.2009.02.013 10.1016/j.pnpbp.2013.12.017 10.1038/pr.2014.199 10.1016/0014-2999(82)90599-4 10.1016/S0021-9258(19)30079-1 10.1073/pnas.1323287111 10.1016/j.physbeh.2019.02.006 10.1016/j.brainresprot.2004.04.002 10.1093/nar/gku1026 10.1016/j.heliyon.2019.e02037 10.1016/0006-8993(85)90857-1 10.1016/j.neubiorev.2005.06.007 10.1016/j.tins.2007.03.006 10.1038/sj.jp.7211157 10.1007/s12035-011-8214-0 10.1016/S0028-3908(97)00051-8 10.1016/S0006-8993(99)01224-X 10.1211/jpp/61.09.0016 10.1016/S0014-2999(98)00591-3 10.1152/physrev.00015.2019 10.3389/fncir.2020.590299 10.3389/fnins.2017.00295 10.1016/0014-4886(82)90115-7 10.1001/archneur.1979.00500390067007 10.1186/1742-2094-10-145 10.1186/s12974-016-0688-2 10.1002/brb3.1028 10.1177/1178646919873925 10.1016/S0140-6736(05)66915-2 10.1038/sj.mp.4002100 10.1186/s13229-018-0243-3 10.1038/sj.npp.1300476 10.1055/s-2007-1014472
Pediatric Research; Miura S, Tsuchie K et. al.

Apr 1st, 2021 - Severe neonatal hyperbilirubinemia has been known to cause the clinical syndrome of kernicterus and a milder one the syndrome of bilirubin-induced neurologic dysfunction (BIND). BIND clinically manifests itself after the neonatal period as develop...

The Enigma of Preterm Late Hyperbilirubinemia Kernicterus in Japan.
https://doi.org/10.1159/000514758
Neonatology Watchko JF

Mar 28th, 2021 - The Enigma of Preterm Late Hyperbilirubinemia Kernicterus in Japan.|2021|Watchko JF,|

Neonatal hereditary spherocytosis caused by a de novo frameshift mutation of the SPTB g...
https://doi.org/10.1097/MD.0000000000024804
Medicine Zhang Y, Shao S et. al.

Mar 25th, 2021 - The etiology of non-immune hydrops fetalis is complex, and its prognosis is poor. One of its main causes is anemia. There are few reports on hydrops fetalis due to anemia caused by hereditary spherocytosis (HS), especially regarding its occurrence...

see more →

News  61 results

Malpractice Case: Be Aware When Follow-up Requires Extra Steps
https://www.medscape.com/viewarticle/924898_1

Mar 1st, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

Malpractice Case: Be Aware When Follow-up Requires Extra Steps
https://www.staging.medscape.com/viewarticle/924898

Mar 1st, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

Malpractice Case: Be Aware When Follow-up Requires Extra Steps
https://www.medscape.com/viewarticle/924898

Mar 1st, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

Outcomes After Bone Marrow Transplants Continue to Improve
https://www.medscape.com/viewarticle/924562

Jan 29th, 2020 - The downward trajectory in death rates among bone marrow transplant recipients that was first documented in the early 2000s is continuing, with the latest records showing a substantial drop in primarily nonrelapse mortality (NRM) out to 2017. The ...

Can insulin plus metformin improve pregnancy outcomes in women with type 2 diabetes?
https://www.mdedge.com/fedprac/article/214703/obstetrics/can-insulin-plus-metformin-improve-pregnancy-outcomes-women-type-2/page/0/1?channel=53

Dec 23rd, 2019 - Currently, the multisite MOMPOD trial (Medical Optimization of Management of T2DM Complicating Pregnancy) is randomizing 950 women to insulin plus 1,000 mg metformin twice daily or insulin plus placebo. The primary outcome of the trial is a compos.

see more →